Four AseBio partners will participate in the first IPCEI in the health sector that will mo... 29/05/2024 Healthcare Access to innovation Financing The Major Project of Common European Interest 'Med4Cure' will enable member states to support a total of 14 projects... AseBio
GENESIS Tech Transfer Boost invests €50,000 in the funding round of Ownmed Innovation, wh... 23/05/2024 Healthcare Access to innovation Financing Ownmed Innovation's technology provides an alternative to ostomy bags, allowing patients to have greater autonomy and... Partners - GENESIS Biomed
Spanish biotechs raise 228 million euros in private financing in 2023 15/05/2024 Financing During the AseBio Investor Day, held on May 15th in San Sebastián, AseBio has revealed data on private financing... AseBio
Spanish biotechs raise 228 million euros in private financing in 2023 15/05/2024 During the AseBio Investor Day, held on May 15th in San Sebastián, AseBio has revealed data on private financing... AseBio
Oryzon to provide corporate progress updates at several events in May 09/05/2024 Healthcare Financing Corporate Oryzon Genomics will attend and participate, both as speaker and guest, in different events related to biotechnology and... Partners - Oryzon Genomics
#AseBioID24 | “Being present at Investor Day gives you wings to visualize, work and promot... 08/05/2024 Healthcare Access to innovation Advanced therapies Financing Hector Olabegogeaskoetxea Narbaiza, CEO of MONDRAGON Health, Silver Sponsor of AseBio Investor Day, analyzes the biotech... AseBio
Barcelona Science Park companies receive €85.4 million in investment in 2023, 40% of the ... 07/05/2024 Financing Companies connected to the Barcelona Science Park received €85.4 million in 2023, 38.6% of the total funding in the... Partners - Parc Científic de Barcelona
Oryzon reports financial results and corporate update for quarter ended March 31, 2024 07/05/2024 Healthcare Access to innovation Rare diseases Personalized medicine Advanced therapies Financing Finalizing full data analysis from vafidemstat's PORTICO Phase IIb trial in Borderline Personality Disorder (BPD)... Partners - Oryzon Genomics
#AseBioID24 | "These types of events are essential, considering how difficult it usually i... 06/05/2024 Healthcare Financing We analyze the challenges that biotechnology companies face in terms of financing, with David Roberto García, Chief... AseBio - Laminar Pharma
#AseBioID24 | 'The Investor Day is a reference event for the national ecosystem primarily,... 03/05/2024 Healthcare Financing We interviewed Roger Pique, General Partner at Inveready, Bronze Sponsor of the AseBio Investor Day 2024. AseBio - Inveready
